New drug trial seeks to control aggressive breast cancer
NCT ID NCT07311993
First seen Jan 06, 2026 · Last updated Apr 16, 2026 · Updated 13 times
Summary
This early-stage study is testing three different dose levels of an experimental drug called CLR 125 in people with advanced triple-negative breast cancer that has returned or stopped responding to other treatments. The main goals are to find the safest and most effective dose for future studies and to understand what side effects patients experience. About 60 participants will receive the drug through an IV infusion every 8 weeks and be closely monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic Florida
NOT_YET_RECRUITINGJacksonville, Florida, 32224, United States
Contact
-
United Theranostics
RECRUITINGGlen Burnie, Maryland, 21061, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
United Theranostics
RECRUITINGPrinceton, New Jersey, 08540, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.